Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) Epidemiology Non-interventional Study (NIS)
NCT05819385 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 312
Last updated 2026-05-07
Summary
This study aims to characterize the epidemiology of interstitial lung diseases (ILD) associated to connective tissue disease (CTD) in Mexico, and to study its correlation with the different comorbidities and treatments used, as well as the possible impacts of these factors on the outcome of progression, exacerbations, and mortality in patients with ILD associated to CTD.
Conditions
- Lung Diseases, Interstitial
Sponsors & Collaborators
-
TIC Social Mexico
collaborator UNKNOWN - lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-18
- Primary Completion
- 2027-12-01
- Completion
- 2027-12-01
Countries
- Mexico
Study Locations
More Related Trials
-
A Non-Interventional Study in Patients With Rheumatoid Arthritis Who Are Treated With RoActemra/Actemra (Tocilizumab)
NCT01893255 ·Status: WITHDRAWN
-
An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis
NCT01543503 ·Status: COMPLETED
-
Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases
NCT02184065 ·Status: COMPLETED
-
Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases
NCT03454932 ·Status: TERMINATED
-
An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor
NCT01557348 ·Status: COMPLETED
-
Clinical Disease Activity and Modulation of Synovial Lymphoid Structures and B Cell Function in Rheumatoid Arthritis
NCT02528292 ·Status: UNKNOWN
-
Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes
NCT02469753 ·Status: COMPLETED ·Phase: PHASE3
-
Observation of Treatment With Certolizumab Pegol in Daily Practice
NCT01069419 ·Status: COMPLETED
-
A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis
NCT01904292 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D)
NCT01604343 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study of Janus Kinase (JAK) Inhibitors Vs Tumor Necrosis Factor (TNF) Inhibitors in Rheumatoid Arthritis
NCT05567380 ·Status: UNKNOWN
-
Effect Of Anti TNF Alpha Therapy And Their Adverse Effects In Ankylosing Spondylitis In A North Indian Population
NCT01361542 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis
NCT03355573 ·Status: COMPLETED ·Phase: PHASE2
-
Italian Registry of Arthritis on Biologic Therapy
NCT01543594 ·Status: RECRUITING
-
An Observational Study of RoActemra/Actemra (Tocilizumab) in Rheumatoid Arthritis Patients
NCT01615419 ·Status: COMPLETED
-
Faecal Analyses in Spondyloarthritis Therapy
NCT03839862 ·Status: RECRUITING
-
The Role of IL-23 in Chronic Inflammatory Disease: Exploring the Cellular and Molecular Targets of IL-23 Signaling in Peripheral and Axial Spondyloarthritis
NCT05290363 ·Status: RECRUITING ·Phase: NA
-
Study of Arthritis and Related Conditions
NCT00006333 ·Status: COMPLETED
-
National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs)
NCT01095393 ·Status: COMPLETED
-
Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA)
NCT02097524 ·Status: COMPLETED ·Phase: PHASE1
-
Is the Human Microbiome Altered in Patients With Axial Spondyloarthritis?
NCT02962479 ·Status: UNKNOWN
-
Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions
NCT03510442 ·Status: RECRUITING
-
Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade
NCT02605642 ·Status: COMPLETED
-
Long-term Efficacy, Safety and Tolerability of ACZ885 in Patients With Rheumatoid Arthritis
NCT00554606 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Tocilizumab in Participants With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Non-Biological Disease-modifying Anti-rheumatic Drugs (DMARDs)
NCT01617005 ·Status: COMPLETED